FDA Opens Floodgates for Banned Peptides: A Recipe for Disaster? The Food and Drug Administration's decision to clear the way for six banned peptides has sent shockwaves through the medical community.
The move raises serious questions about regulatory capture of government agencies by special interest groups.
At first glance, the change may seem like a harmless tweak to the FDA's rules, allowing compounding pharmacies to produce these peptides with a doctor's permission.